I Mab Stock Analysis

IMAB Stock Analysis Notes

About 31.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. I Mab recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people. To learn more about I Mab call XiYong MBA at 240 745 6330 or check out https://ir.i-mabbiopharma.com.

I Mab Investment Alerts

I Mab Upcoming and Recent Events

IMAB Largest EPS Surprises

View All Earnings Estimates

IMAB Stock Institutional Investors

Note, although I Mab's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

IMAB Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.74 M.

IMAB Profitablity

Management Efficiency

I Mab has return on total asset (ROA) of (0.2925) % which means that it has lost $0.2925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7172) %, meaning that it created substantial loss on money invested by shareholders. I Mab's management efficiency ratios could be used to measure how well I Mab manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.59. In addition to that, Return On Capital Employed is expected to decline to -0.59. At present, I Mab's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 5.2 B, whereas Non Current Assets Total are forecasted to decline to about 262.5 M.

Technical Drivers

As of the 26th of November, I Mab retains the coefficient of variation of (2,318), and Market Risk Adjusted Performance of 0.2743. I Mab technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.

I Mab Price Movement Analysis

I Mab Outstanding Bonds

I Mab Predictive Daily Indicators

I Mab Forecast Models

I Mab's time-series forecasting models are one of many I Mab's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary I Mab's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how I Mab prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IMAB shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as I Mab. By using and applying IMAB Stock analysis, traders can create a robust methodology for identifying IMAB entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. IMAB analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. IMAB analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

I Mab stock analysis indicators help investors evaluate how I Mab stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading I Mab shares will generate the highest return on investment. By understating and applying I Mab stock analysis, traders can identify I Mab position entry and exit signals to maximize returns.

When running I Mab's price analysis, check to measure I Mab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Mab is operating at the current time. Most of I Mab's value examination focuses on studying past and present price action to predict the probability of I Mab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Mab's price. Additionally, you may evaluate how the addition of I Mab to your portfolios can decrease your overall portfolio volatility.